Cargando…
Nanopharmaceuticals (part 2): products in the pipeline
In part I of this review we assessed nanoscience-related definitions as applied to pharmaceuticals and we discussed all 43 currently approved drug formulations, which are widely publicized as nanopharmaceuticals or nanomedicines. In continuation, here we review the currently ongoing clinical trials...
Autores principales: | Weissig, Volkmar, Guzman-Villanueva, Diana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334342/ https://www.ncbi.nlm.nih.gov/pubmed/25709446 http://dx.doi.org/10.2147/IJN.S65526 |
Ejemplares similares
-
Nanopharmaceuticals (part 1): products on the market
por: Weissig, Volkmar, et al.
Publicado: (2014) -
Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods
por: Souto, Eliana B., et al.
Publicado: (2020) -
Nanopharmaceutics
por: Ali, Javed
Publicado: (2011) -
Trends in Nanopharmaceutical Patents
por: Antunes, Adelaide, et al.
Publicado: (2013) -
Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
por: Salama, Lavinia, et al.
Publicado: (2020)